Inventor · Shanghai, CN

Qilong Wu

24Patents
6h-index
45Co-inventors
61Inventor score

Filing activity: Dec 19, 2014 → Mar 17, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9815901B2 Treatment of cancer using a CD123 chimeric antigen receptor Chemistry; Metallurgy 80 Active
US9777061B2 Treatment of cancer using a CD33 chimeric antigen receptor Chemistry; Metallurgy 74 Active
US10174095B2 Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 27 Active
US10287354B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 21 Active
US10640569B2 Human mesothelin chimeric antigen receptors and uses thereof Chemistry; Metallurgy 8 Active
US11084880B2 Anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 8 Active
US9862760B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 6 Active
US10654914B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 5 Active
US10450366B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 5 Active
US10435460B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 5 Active
US10577417B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 4 Active
US11161894B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 2 Active
US11639378B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 1 Active
US10568947B2 Treatment of cancer using a CLL-1 chimeric antigen receptor Chemistry; Metallurgy 1 Active
US10851166B2 Treatment of cancer using a CD33 chimeric antigen receptor Chemistry; Metallurgy 1 Active
US11459390B2 Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor Chemistry; Metallurgy 0 Active
US12214037B2 Treatment of cancer using humanized anti-BCMA chimeric antigen receptor Chemistry; Metallurgy 0 Active
US12077571B2 Polyomavirus neutralizing antibodies Emerging Cross-Sectional Technologies 0 Active
US10703819B2 Treatment of cancer using a CD123 chimeric antigen receptor Chemistry; Metallurgy 0 Active
US11999794B2 Human mesothelin chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11591404B2 Treatment of cancer using a CD123 chimeric antigen receptor Chemistry; Metallurgy 0 Active
US12338287B2 Treatment of cancer using a CD33 chimeric antigen receptor Chemistry; Metallurgy 0 Active
US11981731B2 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Chemistry; Metallurgy 0 Active
US11578130B2 Regulatable chimeric antigen receptor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.